Clinical Trials Directory

Trials / Terminated

TerminatedNCT00512031

Characterizing PAI-1 Modulation on Monocyte Adhesion

Characterizing the Effects of PAI-1 Modulation on Human Monocyte Function - The Effect of PAI-1 Post-transcriptional Regulation on Human Monocyte Adhesion

Status
Terminated
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Vanderbilt University · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

To determine how altering the expression of a gene known as PAI-1 may affect the adhesive capacity of cells that play a critical role in the developement of human atherosclerosis.

Detailed description

The principal aim of this study is to determine if molecular regulation of the human gene PAI-1 alters the migratory properties of human myeloid and endothelial cells sufficiently enough to regulate entry and exit from the vascular space. Human monocyte become the key cellular orchestrators of human atherosclerotic plaque. We believe that a "loss" of PAI-1 activity may promote a pro-atherogenic effect in human vasculature thereby defining a novel atheroprotective effect for PAI-1 when expressed at normal levels in humans. By using RNA interference to achieve PAI-1 gene, we hope to elucidate the mechanistic basis of how PAI-1 regulation may affect human migration within the vasculature.

Conditions

Timeline

Start date
2007-01-01
Primary completion
2011-07-01
Completion
2011-07-01
First posted
2007-08-07
Last updated
2011-07-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00512031. Inclusion in this directory is not an endorsement.

Characterizing PAI-1 Modulation on Monocyte Adhesion (NCT00512031) · Clinical Trials Directory